HArmonyCa vs. Radiesse vs. Sculptra

Collagen-stimulating injectables have become one of the most discussed categories in medical aesthetics. Unlike traditional dermal fillers that add volume and dissolve without lasting structural change, biostimulators work with the body’s own biology to trigger the production of new collagen, elastin, and other structural proteins that firm, lift, and improve skin quality over time.

In Canada, three biostimulators are now authorized by Health Canada: HArmonyCa, Radiesse, and Sculptra. All three share the same broad goal. How they achieve it, and which one suits a given patient, depends on composition, mechanism, treatment timeline, and individual anatomy.

This article covers the science behind each treatment, their key differences, and the patient profiles where each tends to perform best.

Table of Contents:

What Is a Collagen Biostimulator?

HArmonyCa: The Hybrid Approach

Radiesse: Calcium Hydroxyapatite Biostimulation

Sculptra: Poly-L-Lactic Acid Collagen Rebuild

Full Comparison Table

Which Treatment Suits Which Patient?

Can These Treatments Be Combined?

FAQ

What Is a Collagen Biostimulator?

Collagen is the structural protein responsible for skin firmness, elasticity, and support. Production begins declining in the mid-twenties at approximately 1% per year. Over time, this cumulative loss manifests as progressive volume depletion, skin laxity, and loss of facial definition.

A collagen biostimulator is an injectable treatment that addresses this by stimulating fibroblasts, the cells responsible for synthesizing collagen and elastin, to produce new structural tissue. Rather than replacing lost volume with a foreign substance, biostimulators prompt the skin to rebuild its own framework.

According to global consumer research conducted by Allergan Aesthetics involving 12,360 respondents, 96% reported a concern about an area of their face, with 40% concerned about skin quality and 39% about loss of skin tightness. When asked whether they would consider a non-surgical treatment that stimulates the skin’s own collagen production, two-thirds said they would (Allergan Consumer Beauty Insights Study 2021, via Allergan Aesthetics Canada).

HArmonyCa, Radiesse, and Sculptra each approach collagen stimulation through different active ingredients and mechanisms.

HArmonyCa: The Hybrid Approach

What it is

HArmonyCa is a dual-action injectable. It received Health Canada authorization in May 2026, making it the first hybrid HA + CaHA injectable authorized in Canada (Allergan Aesthetics Canada).

It is composed of two active ingredients combined in a single syringe using Allergan’s patented DART (Dual Action Rejuvenating Technology):

• Hyaluronic acid (HA): Provides immediate volumization and structural support
• Calcium hydroxyapatite (CaHA) microspheres: Stimulate fibroblast activity and progressive collagen production over time

How it works

The HA component acts immediately after injection, adding volume and creating a visible lifting effect in the treated area. It also functions as a carrier gel, distributing the CaHA microspheres evenly within the deeper tissue layers so that biostimulation is consistent across the treatment zone.

Over the following weeks and months, the CaHA microspheres activate fibroblasts to produce new collagen and elastin. A clinical study using ultrasound and elastography confirmed increases in skin density, viscoelasticity, and firmness beginning at 60 days post-treatment, with collagen production confirmed at 180 days. Facial tissue volume increased by a median of 2.2 mm at 180 days, as measured by Vectra H2 3D imaging (Urdiales-Gálvez et al., Journal of Cosmetic Dermatology, 2023).

Clinical outcomes

In a post-marketing clinical study of 162 patients, 91.6% showed measurable improvement in the general appearance of treated facial areas. Patient satisfaction was rated 4.1 out of 5 at up to 19 months post-treatment (Allergan Aesthetics Canada).

Key characteristics

• Immediate effect: Yes. Visible lift present on the day of treatment
• Collagen stimulation: Yes. Progressive over three to six months
• Reversibility: Partial. The HA component can be partially addressed with hyaluronidase; the CaHA component is not reversible
• Duration: Up to 18 months
• Typical sessions: 1 to 2
• Primary treatment areas: Cheeks, midface, jawline, lower face

Patient profile

HArmonyCa is most suitable for adults with mild to moderate facial volume loss who want both an immediate visible result and long-term collagen stimulation. It is also relevant for patients experiencing facial volume changes related to significant weight loss, including those on GLP-1 medications.

Radiesse: Calcium Hydroxyapatite Biostimulation

What it is

Radiesse is a Health Canada-authorized injectable composed of calcium hydroxyapatite (CaHA) microspheres suspended in a carboxymethylcellulose (CMC) gel. CaHA is a biocompatible mineral compound with a long history in aesthetic medicine.

How it works

When injected, Radiesse provides immediate structural volumization through the physical presence of the CaHA-CMC gel. Simultaneously, the CaHA microspheres function as a cellular scaffold. The surrounding tissue responds by producing collagens I and III, elastin, proteoglycans, and new vasculature.

A comprehensive narrative review published in the Aesthetic Surgery Journal describes this mechanism: CaHA drives soft tissue regeneration through a cell-biomaterial interaction, with minimal adaptive immune cell recruitment and without chronic inflammation, distinguishing it from some other biostimulatory materials (Aguilera et al., Aesthetic Surgery Journal, 2023).

Radiesse does not contain hyaluronic acid. The immediate effect is structural, produced by the volume of the CaHA-CMC gel itself rather than the hydrating, softening effect of HA.

Key characteristics

• Immediate effect: Yes. Structural volumization present on the day of treatment
• Collagen stimulation: Yes. Progressive and durable
• Reversibility: No
• Duration: Up to 18 months
• Typical sessions: 1 to 2
• Primary treatment areas: Cheeks, jawline, lower face, hands

Patient profile

Radiesse suits patients seeking a pure CaHA biostimulatory approach without a hyaluronic acid component. It is specifically indicated for hand rejuvenation in addition to facial areas, which distinguishes it from the other two options. It is a well-established treatment with an extensive clinical evidence base for patients and practitioners familiar with biostimulators.

Sculptra: Poly-L-Lactic Acid Collagen Rebuild

What it is

Sculptra (Galderma) is a Health Canada-authorized injectable poly-L-lactic acid (PLLA) biostimulator. PLLA is a biodegradable synthetic polymer that has been used in medical applications, including dissolvable sutures, for decades (Cleveland Clinic).

How it works

Unlike HArmonyCa and Radiesse, Sculptra provides no immediate volumizing effect. PLLA microparticles are injected into the deeper layers of the skin, where they trigger a gradual inflammatory response that stimulates fibroblast proliferation and new collagen synthesis. Because this cellular cascade develops over time, the visible result emerges progressively across multiple treatment sessions spaced four to six weeks apart (Narins et al., PMC, 2012).

Sculptra gradually improves overall skin quality by stimulating your body’s natural collagen production. As collagen is restored, the skin becomes firmer, thicker, smoother, and more elastic, with visible improvements in texture, fine lines, radiance, and overall skin quality. Some patients also notice a subtle improvement in the appearance of enlarged pores as the skin becomes more structurally supported. Sculptra has the longest documented results of the three authorized biostimulators.

Key characteristics

• Immediate effect: No. Results develop gradually over weeks to months
• Collagen stimulation: Yes. Gradual and diffuse over multiple sessions
• Reversibility: No
• Duration: Up to 24 months or more, depending on individual response and maintenance
• Typical sessions: 2 to 3 minimum, scheduled 4 to 6 weeks apart
• Primary treatment areas: Face, neck, décolletage, body areas (arms, abdomen)

Patient profile

Sculptra is well suited for patients experiencing generalized collagen loss, skin laxity, or gradual age-related volume depletion who prefer subtle, progressive improvement rather than immediate correction. It is particularly effective for treating larger areas where improved skin quality and diffuse collagen stimulation are desired, such as the temples, cheeks, neck, décolletage, and selected body areas.

Full Comparison Table

Which Treatment Suits Which Patient?

The right biostimulator depends on the patient’s anatomy, degree of volume loss, preferred timeline, and treatment goals. No single treatment is universally superior.

HArmonyCa may be most appropriate when:

• The patient wants a visible result on the day of treatment alongside long-term collagen benefits
• Volume loss is mild to moderate, primarily in the cheeks or lower face
• The patient is new to biostimulators and prefers the reassurance of an immediate change
• Facial volume loss is related to significant weight loss or GLP-1 medication use
• A single-session approach addressing both structure and collagen is preferred

Radiesse may be most appropriate when:

• A pure CaHA biostimulatory approach, without HA, is clinically indicated
• Structural contouring is the primary objective
• Hand rejuvenation is part of the treatment plan
• The patient and practitioner are familiar with CaHA as a standalone biostimulator

Sculptra may be most appropriate when:

• The patient can commit to multiple sessions over several months
• A gradual, diffuse result is preferred over an immediate volumizing change
• The longest possible duration between maintenance treatments is the priority

A medical consultation with a qualified aesthetic provider is the appropriate way to determine which treatment aligns with a patient’s specific anatomy and goals.

Can These Treatments Be Combined?

In clinical practice, biostimulators are often used alongside one another or in different anatomical areas within a broader treatment plan. For example, a patient might receive a hybrid HA + CaHA injectable in the midface for immediate structural correction, while Sculptra addresses the neck or décolletage with a more diffuse, gradual approach.

Combination protocols are patient-specific and require a full consultation to design appropriately. The decision rests on the provider’s assessment of the patient’s anatomy, skin quality, and treatment priorities.